SCHEMBL6664796

SCHEMBL6664796

Cc1ccc2ncnc(Nc3cccc(OCc4ccccc4)c3)c2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.67
MAPK1 P28482 2/20 0.67
KDM4E B2RXH2 1/20 0.67
EGFR P00533 10/20 0.63
ERBB2 P04626 6/20 0.63
AURKB Q96GD4 2/20 0.58
CLK4 Q9HAZ1 2/20 0.58
CHEK2 O96017 1/20 0.58
ROS1 P08922 1/20 0.58
FLT3 P36888 1/20 0.58
ERBB4 Q15303 1/20 0.58
MKNK2 Q9HBH9 1/20 0.58
HPGD P15428 2/20 0.57
MAPT P10636 2/20 0.57
ALDH1A1 P00352 1/20 0.57
DYRK3 O43781 1/20 0.56
MAP4K4 O95819 1/20 0.56
PDGFRA P16234 1/20 0.56
LTK P29376 1/20 0.56
GRK5 P34947 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6663913 0.89 EGFR (0.79) HTTMAPK1KDM4EEGFRERBB2
SCHEMBL1387183 0.87 EGFR (0.75) HTTKDM4EEGFRERBB2AURKB
Hydrochloric Acid SCHEMBL8807683 0.86 EGFR (0.73) HTTEGFRERBB2AURKBCLK4
SCHEMBL14595168 0.83 EGFR (0.74) HTTMAPK1KDM4EEGFRERBB2
SCHEMBL2101381 0.82 HTT (1.00) HTTMAPK1KDM4EEGFRERBB2
SCHEMBL5569459 0.81 HTT (0.69) HTTMAPK1KDM4EEGFRERBB2
SCHEMBL8871863 0.80 EGFR (0.82) HTTMAPK1KDM4EEGFRERBB2
SCHEMBL5569022 0.78 HTT (0.72) HTTMAPK1KDM4EEGFRERBB2
SCHEMBL8870651 0.78 EGFR (0.81) MAPK1KDM4EEGFRERBB2ERBB4
SCHEMBL16545883 0.78 EGFR (0.64) HTTEGFRERBB2ERBB4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004013091-A2 4-ANILIDO SUBSTITUTED QUINAZOLINES AND USE THEREOF AS INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-02-12 WO claimed
WO-2004013091-A2 4-ANILIDO SUBSTITUTED QUINAZOLINES AND USE THEREOF AS INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-02-12 WO disclosed